{"id":48523,"date":"2026-04-07T14:23:37","date_gmt":"2026-04-07T18:23:37","guid":{"rendered":"https:\/\/tvdelmarva.com\/wp\/german-pharmaceutical-giant-bayer-says-new-u-s-tariffs-wont-impact-business-goals\/"},"modified":"2026-04-07T14:23:37","modified_gmt":"2026-04-07T18:23:37","slug":"german-pharmaceutical-giant-bayer-says-new-u-s-tariffs-wont-impact-business-goals","status":"publish","type":"post","link":"https:\/\/tvdelmarva.com\/wp\/german-pharmaceutical-giant-bayer-says-new-u-s-tariffs-wont-impact-business-goals\/","title":{"rendered":"German Pharmaceutical Giant Bayer Says New U.S. Tariffs Won’t Impact Business Goals"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n

A senior executive at German pharmaceutical company Bayer told reporters Tuesday that recently announced federal tariffs on imported medications won’t force the company to revise its business projections for 2026.<\/p>

Sebastian Guth, who serves as Chief Operating Officer for Bayer Pharmaceuticals and heads the company’s U.S. operations, explained that the drugmaker had already factored potential tariffs into its planning. “We feel that we’ve appropriately anticipated tariffs as we think about our 2026 guidance,” Guth stated during an interview.<\/p>

The executive expressed confidence in the company’s position, noting that existing trade agreements between the United States and European Union provide some protection. Under last year’s deal, tariff rates on most European goods, including pharmaceutical products, cannot exceed 15 percent.<\/p>

Earlier this year in March, Bayer released financial projections showing expected earnings before interest, taxes, depreciation and amortization of between 9.6 billion and 10.1 billion euros for 2026. This represents growth from the company’s 2025 EBITDA figure of 9.669 billion euros.<\/p>

The tariff policy stems from an executive order signed by President Donald Trump last week, targeting brand-name prescription drugs brought into the United States from overseas. Companies can avoid these fees by agreeing to government pricing negotiations or promising to manufacture their products domestically.<\/p>

Implementation of these tariffs is set to begin in September for most pharmaceutical companies.<\/p>

While sixteen major global drugmakers have already negotiated agreements with federal officials to exempt billions of dollars in medications from the new tariffs, Bayer was not included in those initial discussions. Guth would not discuss whether his company has since engaged with the Trump administration about potential exemptions.<\/p>

The executive also highlighted a separate trade agreement between Britain and the United States as a potential model for other nations. Under that arrangement, British pharmaceutical companies receive tariff-free access to American markets in exchange for higher domestic drug prices.<\/p>

The British deal requires increasing medicine expenditures from 0.3 percent of the country’s gross domestic product to 0.35 percent by 2028, eventually reaching 0.6 percent by 2035. Guth suggested this framework could guide how other wealthy nations approach pharmaceutical pricing reforms.<\/p>

“There’s an acknowledgment that it isn’t going to happen overnight, but will happen over time,” Guth said regarding these gradual pricing adjustments.<\/p>","protected":false},"excerpt":{"rendered":"

Bayer’s U.S. operations chief says the company won’t need to change its 2026 financial projections despite new federal tariffs on imported drugs. The German pharmaceutical company feels protected by existing trade agreements with the European Union that limit tariff rates.<\/p>\n","protected":false},"author":4,"featured_media":48522,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[834],"tags":[],"class_list":["post-48523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/04\/news-1775586216929.jpg?fit=450%2C313&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pbtNqq-cCD","jetpack-related-posts":[{"id":65189,"url":"https:\/\/tvdelmarva.com\/wp\/german-pharmaceutical-giant-bayer-reports-strong-q1-earnings-growth\/","url_meta":{"origin":48523,"position":0},"title":"German Pharmaceutical Giant Bayer Reports Strong Q1 Earnings Growth","author":"Admin","date":"May 12, 2026","format":false,"excerpt":"Bayer announced first-quarter operating profits increased 9% beyond analyst predictions, primarily fueled by strong performance in their agricultural division. The company's soybean seed business drove much of the growth following the settlement of a licensing disagreement with competitor Corteva.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778566960019.jpg?fit=450%2C313&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":23053,"url":"https:\/\/tvdelmarva.com\/wp\/bayer-says-glyphosate-supply-secure-globally-despite-us-production-concerns\/","url_meta":{"origin":48523,"position":1},"title":"Bayer Says Glyphosate Supply Secure Globally Despite US Production Concerns","author":"Admin","date":"February 19, 2026","format":false,"excerpt":"German pharmaceutical giant Bayer responded to a presidential executive order regarding glyphosate production, stating that international supplies of the herbicide will remain stable. The company has been dealing with billions in cancer-related lawsuits while being the sole US manufacturer of the widely-used weedkiller.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1771499938814.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":31435,"url":"https:\/\/tvdelmarva.com\/wp\/german-drug-giant-bayer-forecasts-11-7-billion-in-annual-profits\/","url_meta":{"origin":48523,"position":2},"title":"German Drug Giant Bayer Forecasts $11.7 Billion in Annual Profits","author":"Admin","date":"March 4, 2026","format":false,"excerpt":"Pharmaceutical and agricultural company Bayer announced Wednesday its financial projections for the upcoming year. The German corporation expects to generate between $10.4 billion and $11.7 billion in adjusted earnings.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772611496095.jpg?fit=450%2C310&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":25654,"url":"https:\/\/tvdelmarva.com\/wp\/german-drug-giant-bayer-takes-legal-action-against-johnson-johnson\/","url_meta":{"origin":48523,"position":3},"title":"German Drug Giant Bayer Takes Legal Action Against Johnson & Johnson","author":"Admin","date":"February 23, 2026","format":false,"excerpt":"Pharmaceutical company Bayer has initiated legal proceedings in New York against Johnson & Johnson and its subsidiary Janssen Biotech. The lawsuit centers around Bayer's prostate cancer medication Nubeqa.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1771863511432.jpg?fit=450%2C285&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":62482,"url":"https:\/\/tvdelmarva.com\/wp\/german-pharma-giant-bayer-acquires-biotech-firm-for-2-45-billion\/","url_meta":{"origin":48523,"position":4},"title":"German Pharma Giant Bayer Acquires Biotech Firm for $2.45 Billion","author":"Admin","date":"May 6, 2026","format":false,"excerpt":"Pharmaceutical company Bayer announced Wednesday it will acquire biopharmaceutical firm Perfuse Therapeutics in a deal worth up to $2.45 billion. The acquisition is designed to strengthen Bayer's eye care treatment development portfolio.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1778052230771.jpg?fit=450%2C313&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":53973,"url":"https:\/\/tvdelmarva.com\/wp\/federal-judge-denies-bayers-attempt-to-stop-jj-cancer-drug-advertising\/","url_meta":{"origin":48523,"position":5},"title":"Federal Judge Denies Bayer’s Attempt to Stop J&J Cancer Drug Advertising","author":"Admin","date":"April 17, 2026","format":false,"excerpt":"A Manhattan federal judge has turned down Bayer's request to halt Johnson & Johnson's marketing claims about its prostate cancer medication Erleada. The German pharmaceutical company alleged J&J was making false statements about the drug's effectiveness compared to Bayer's competing treatment Nubeqa.","rel":"","context":"In "Business"","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/04\/news-1776482535813.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/48523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/comments?post=48523"}],"version-history":[{"count":0,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/48523\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media\/48522"}],"wp:attachment":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media?parent=48523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/categories?post=48523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/tags?post=48523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}